Major airline partner shutting down base at Burbank airport
On Monday, budget airline Avelo announced it would be shuttering its Southern California base, moving its planes to various hubs across the country and offering its California-based staff the opportunity to transfer elsewhere.
For more than four years, Avelo has been operating out of the Burbank airport, establishing it as its west coast base. The airline launched under its current brand name during the height of the coronavirus pandemic, a move that was deemed risky at the time by some industry analysts.
The ultra-low-cost carrier quickly expanded operations in Burbank, adding flights to various parts of Northern California, Oregon and, briefly, Montana.
In 2023, the airline celebrated flying its 1 millionth passenger, and even described its Burbank flights as being among its most successful offerings, accounting for one-third of its total customers at the time.
But airline officials say the company has been hit hard with new financial challenges that have made it increasingly difficult to provide service to its West Coast destinations.
On Monday, CEO Andrew Levy confirmed that Avelo would be reducing its number of planes flying out of Los Angeles County to one by mid-August, before shutting the base down entirely on Dec. 2, 2025. That closure will coincide with Avelo ceasing all West Coast operations, company officials confirmed.
Levy described the decision as a difficult one, adding that there's no singular reason for Avelo ceasing operations with one of its longest airport partners.
'We believe the continuation of service from [Hollywood Burbank Airport] in the current operating environment will not deliver adequate financial returns in a highly competitive backdrop,' he said.
Avelo will relocate its current Burbank fleet to different locations where Levy says the company sees more 'efficient longer-term growth prospects,' as it attempts to build out its East Coast operation.
All California-based employees will be given the opportunity to transfer to another Avelo base, Levy said, all of which are on the Eastern Seaboard, including Hartford, Connecticut; Charlotte, North Carolina; and Wilmington, Delaware.
Passengers with existing flights can cancel their trips online and receive a refund.
In addition to flying ticket-purchasing passengers out of Los Angeles County, Avelo also received backlash and calls for boycott after it was announced the airline had partnered with the U.S. Department of Immigration and Customs Enforcement to provide charter flights to assist with its deportation efforts. Those flights were specifically operated out of the Mesa Gateway Airport in Arizona, but a push for a company boycott was widespread on social media.
A spokesperson for the company denied that the decision was related to its charter program in Arizona, and said the company had invested 'significant time, resources and efforts,' that have not produced 'results necessary' to continue its West Coast presence.
Request for comment from the Hollywood Burbank Airport regarding the news was directed back to Avelo.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Defi Tokens Are Soaring, Leaving Behind OG Coins Like LTC, BCH and XMR
Bitcoin's surge to an all time high on Thursday evoked mixed reactions from altcoins, with some outperforming the largest cryptocurrency by market cap and others lagging behind. And that's split along industry lines. Tokens associated with decentralized finance (DeFi) and those from layer-2 blockchains are outperforming as investors transition to a risk-on approach. Others, such as tron (TRX), bitcoin cash (BCH), litecoin (LTC) and monero (XMR) are, in comparison, barely moving. Even solana (SOL), the darling of the previous drive to record highs, seems to be taking a back seat, rising just 3.9% while the likes of sei (SEI), ethena (ENA) and optimism (OP) are celebrating gains of as much as 28%. "Altcoins are leading the pack in this latest rally," Thomas Perfumo, Kraken's global economist, said in an email. A drop in bitcoin dominance is "reinforcing a broad-based rally with altcoins leading the charge." During the 2017 and 2021 runs to record highs, bitcoin dominance — a measure of BTC's share of the total crypto market —rose rapidly. On Thursday's rally, it fell to 63.5% from 64%, indicating a shift in emphasis toward the altcoin market Crypto markets are cyclical by nature. They run without interruption 24 hours a day against a backdrop of high volatility and low liquidity which can create an emotional trading environment. In previous cycles, altcoins often moved in unison, rising as bitcoin consolidated and dropping en masse when it rose or fell. This time, however, seems different, possibly due to the increased participation of institutions in the the industry. The rise in DeFi tokens can be attributed to increasing institutional interest in ether (ETH), which could pave the way for a search for yield with firms battling to secure the highest returns. The same can be said for layer-2 networks. As institutions run into the Ethereum blockchain's issues with latency and efficiency, they may consider networks like Arbitrum that allow liquidity to flow from decentralized exchanges to staking protocols at a fast rate. That network's ARB token is up 15% in the past 24 hours. Still, Petr Kozyakov, CEO at payments firm Mercuryo, said the rise in altcoins will be short-lived. "While altcoins are also in the green with Ethereum spiking past the $3,000 mark, the underlying 'orange pill' narrative remains steadfastly in place," he said. "Bitcoin's growing status as a store of value is one that more and more big players and institutions are simply unable to ignore." That's not a narrative that finds much support from Arthur Hayes, the BitMEX founder turned fund manager. 'Get ready for a monster alt season,' he told his followers on X after predicting that ETH would reach $10,000 this cycle. If Hayes' prediction holds true, bitcoin could face short-term difficulty as liquidity will inevitably flow into the altcoin market as traders attempt to capture speculative gains. This could also be a hammer blow to the old-school crypto coins, which all lack major catalysts for a boost. Sign in to access your portfolio
Medscape
15 minutes ago
- Medscape
Revolutionizing Anesthesia Drug Management and Integrity
Stocking and restocking anesthesia carts is tedious and meticulous — and it's highly regulated. Anesthesiologists have direct and extensive access to controlled drugs in a hospital setting, particularly potent opioids and sedatives, which makes these processes vulnerable to the potential of abuse. Within the anesthesia ecosystem, the doctor has a partner in the stocking and restocking process, and that's the hospital pharmacy staff. This team has so much reporting to do: logging which medications were used by which operating teams and on which patients — data that ultimately get reported to the Drug Enforcement Administration. Errors in any part of the dispensing, stocking, and securing process could result in waste, fines, medication errors, or worse. Hospitals have been on the search for help. Several companies have focused on what's called RAIN RFID. The technology uses passive ultrahigh frequency waves to essentially perform the function of Bluetooth or Wi-Fi for short-range device communication. It's available to hospitals to help with everything from patient tracking to equipment security and compliance. For anesthesia departments, the company Intelliguard created what it calls the Mira Ecosystem. It's built on RAIN RFID and monitors each vial of medication through its entire journey, filling clinical, compliance, and supply chain functions. Tray Setups and Refills Are Quick, Easy, and Traceable According to Intelliguard, about 90% of its systems are currently deployed to serve anesthesia departments. When vials of medication arrive at the pharmacy, a technician applies the Mira tag to each vial, and immediately, the system begins tracking each individual one. 'Our system reads each of the 96-bit unique IDs and then associates those unique IDs with the medication. So now each of those IDs is associated with rocuronium, for example, and the company that made it, the serial number, and the expiration and the lot number,' said Paul Elizondo, Intelliguard's chief innovation officer. 'From then on, when our system sees that 96-bit unique ID, it associates it with the medication in a database. It displays that on the screen, and we know exactly what that medication is now.' Paul Elizondo The system tracks each vial of medication throughout its journey at the hospital, giving pharmacy managers and hospital administrators instant, real-time visibility into where each vial is and when. In terms of daily pharmacy tasks, making up medication trays for anesthesiologists is made nearly foolproof, reducing medication errors. 'The hospitals using our system will place these RFID-tagged medications into the tray, then they will place that tray into our enclosure,' said Elizondo. 'In 6 seconds, we read every single tag in that tray, and we let them know if that formula, if what's in the tray, matches the formulary to which they're building right at that time.' The system can also check to ensure there are no expired or recalled medications in the tray. The real-time savings come, though, when the anesthesiologist returns the tray at the end of the day. Rady Children's Hospital in San Diego is using this system. Performance improvement pharmacist Ann McKinstry explained some of the ways that she's seen return on investment gains. 'Pinpointing the medication location has allowed for a more rapid response to expiry, recalls, and patient care events,' McKinstry said. 'Inpatient pharmacy inventory is tightened by offering a streamlined data review to analyze usage and reducing waste by tightening supply on hand. In addition, RFID tags allow accurate controlled substance reconciliation by monitoring usage, waste, and replenishment down to the minute.' Real-Time Tracking of Medication Location Saves a Life Knowing exactly where your medications are on a real-time basis isn't just important: It can be a matter of life and limb. For example, if a patient with a deadly North American pit viper bite is rolled into your emergency department, as happened at a Bartow, Florida hospital at 1 AM on May 4 — you'd definitely want to know if you have antivenom on hand. Bartow was out. They reached out to Prodigy Health, distributor of specialty pharmaceuticals that supplies medicines to hospitals on a consignment basis. Prodigy runs a 24-hour switchboard and uses RAIN to gain visibility into what is being dispensed by each hospital. The antivenom was quickly located at a hospital in Lutz, Florida, one that had a RAIN RFID cabinet. The request was made, the antivenom was transferred, and the day was saved. Ty Dishman Before this technology, 'This process was manual and time-consuming. Now, with reliable data integrating into our system every 6 seconds, we're able to provide immediate, confident answers to customer inquiries about medication availability and delivery timelines,' said Ty Dishman, CEO of Prodigy Health. 'Instead of saying, 'I think it's there — let me check and call you back,' we can act quickly and efficiently, ensuring life-saving medications are mobilized without delay.' The Competitive Landscape RFID systems are nothing new in the healthcare environment. They're commonly used to track medical equipment and inventory, as well as in staff badging systems. Its use in medication management is fairly recent. Terso Solutions offers a similar suite to the Mira Ecosystem, with the exception of Intelliguard's direct-to-operating room tray system; Avery Dennison Medical and Healthcare provides a wide range of pharmaceutical labeling options, and some options include RFID.
Yahoo
20 minutes ago
- Yahoo
What You Need To Know Ahead of Tyson Foods' Earnings Release
Valued at $19.3 billion by market cap, Springdale, Arkansas-based Tyson Foods, Inc. (TSN) operates as the biggest U.S. chicken company and produces, distributes, and markets chicken, beef, pork, as well as prepared foods. The farm products giant is expected to announce its third-quarter results before the markets open on Monday, Aug. 4. Ahead of the event, analysts expect Tyson Foods to deliver a profit of $0.79 per share, down 9.2% from $0.87 per share reported in the year-ago quarter. On the positive note, the company has a solid earnings surprise history and has surpassed the Street's bottom-line estimates in each of the past four quarters. Palantir Just Launched Warp Speed for Warships. Does That Make PLTR Stock a Buy? This Analyst Just Doubled His Price Target on AMD Stock How High Can Nvidia Stock Go as Jensen Huang Heads to China? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! For the full fiscal 2025, analysts expect TSN to report an EPS of $3.83, up a staggering 23.6% from $3.10 reported in fiscal 2024. In fiscal 2026, its earnings are expected to further grow 10.7% year-over-year to $4.24 per share. TSN stock prices have dropped 5.2% over the past 52 weeks, notably underperforming the S&P 500 Index's ($SPX) 11.6% gains and the Consumer Staples Select Sector SPDR Fund's (XLP) 4.4% uptick during the same time frame. Tyson Foods' stock prices plunged 7.8% following the release of its mixed Q2 results on May 5. Although the company reported hikes in product prices, its volumes remained under pressure. This led to its overall topline remaining flat year-over-year at $13.1 billion, missing the consensus estimates by 61 basis points. Meanwhile, its gross profits took a hit due to rising cost of sales, and its operating cash flows for the quarter dropped 28.1% year-over-year to $846 million. However, its adjusted EPS of $0.92 surpassed the consensus estimates by 8.2%. The stock maintains a consensus 'Moderate Buy' rating overall. Of the 10 analysts covering the TSN stock, opinions include three 'Strong Buys' and seven 'Holds.' Its mean price target of $64 indicates a 17.8% upside potential from current price levels. On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
